Correction to: "Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial"
Headache
.
2024 Mar;64(3):329.
doi: 10.1111/head.14691.
Epub 2024 Feb 26.
PMID:
38407505
PMCID:
PMC10984327
DOI:
10.1111/head.14691
No abstract available
Publication types
Published Erratum